Back to News
Market Impact: 0.3

Guru Fundamental Report for PFE

PFENDAQ
Company FundamentalsCapital Returns (Dividends / Buybacks)Healthcare & BiotechAnalyst InsightsValuation
Guru Fundamental Report for PFE

Validea's guru fundamental report rates Pfizer (PFE) at 85% using Meb Faber's Shareholder Yield Investor model, which prioritizes companies returning cash to shareholders via dividends, buybacks, and debt paydown. This score indicates 'some interest' for investors employing this strategy, positioning PFE as a large-cap growth stock within the Biotechnology & Drugs sector based on its underlying fundamentals and valuation.

Analysis

Pfizer (PFE) has received a moderately positive rating of 85% from Validea's quantitative model based on Meb Faber's Shareholder Yield strategy, which targets companies returning cash to shareholders. This score, classifying PFE as a large-cap growth stock in the Biotechnology & Drugs sector, suggests 'some interest' from the model, as it surpasses the 80% threshold but remains below the 90% 'strong interest' level. The stock passed several key criteria, including Net Payout Yield, Quality and Debt, Valuation, and Relative Strength. However, it is critical to note that despite the model's focus, PFE specifically failed the 'Shareholder Yield' test. This apparent contradiction indicates that while the overall composite score is favorable due to strengths in other areas, the company's capital return profile has a specific weakness according to the strategy's detailed screening.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.60

Ticker Sentiment

NDAQ0.00
PFE0.60

Key Decisions for Investors

  • Investors following shareholder-yield strategies should view the 85% score as a qualified endorsement, recognizing that PFE meets several criteria but is not a top-tier candidate according to this specific model.
  • Further due diligence is required to understand the discrepancy between the passing grade on 'Net Payout Yield' and the failing grade on 'Shareholder Yield' to clarify the precise nature of the company's capital return program.
  • Given that PFE passed on valuation, quality, and relative strength, it may warrant consideration for portfolios that balance capital return objectives with a broader focus on fundamental quality and attractive valuation metrics.